Skip to search form
Skip to main content
Semantic Scholar
All Fields
All Fields
Art
Biology
Business
Computer Science
Chemistry
Economics
Engineering
Environmental Science
Geography
Geology
History
Materials Science
Mathematics
Medicine
Philosophy
Physics
Political Science
Psychology
Sociology
FAQ
Contact Us
•
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Pralatrexate Injection [Folotyn]
National Institutes of Health
Watch Topic
Related topics
Related topics
3 relations
Narrower (1)
2 ML Pralatrexate 20 MG/ML Injection [Folotyn]
Folotyn
Injection
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Identification of An Active, Well-Tolerated Dose of Pralatrexate In Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL): Final Results of a Multicenter Dose-Finding Study.
Steven M Horwitz
,
Youn Hui Kim
,
+11 authors
Madeleine Duvic
2010
Abstract 2800 Background: Pralatrexate (FOLOTYN®) is an antifolate designed for preferential tumor uptake and accumulation…
Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE